DRUG ALBUM PKDHS 2021

BISOPROLOL FUMARATE 2.5 MG
TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C
SPECIAL COUNSELING POINT
No Human Data - Potential Toxicity

Avoid activities requiring coordination until
drug effect are realized. Instruct patient to take

a missed dose as soon as possible, but if the
next dose is in less than 8h, skip the dose. May
mask hypoglycemia symptoms. Advise diabetic
patient to carefully monitor blood sugar levels

37

BISOPROLOL FUMARATE 5 MG TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C
SPECIAL COUNSELING POINT
No Human Data - Potential Toxicity

Avoid activities requiring coordination until
drug effect are realized. Instruct patient to
take a missed dose as soon as possible, but if
the next dose is in less than 8h, skip the dose.
May mask hypoglycemia symptoms. Advise
diabetic patient to carefully monitor blood

sugar levels

38

BROMHEXINE HCL 4MG/5ML ELIXIR

CATEGORY DESCRIPTION
PREGNANCY
LACTATION A

SPECIAL COUNSELING POINT Bromhexine is expected to enter
breast milk, and therefore should be

avoided during lactation

Should be taken with food.
May cause GI discomfort

39

BROMHEXINE HCL 8 MG TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION A

SPECIAL COUNSELING POINT Bromhexine is expected to enter
breast milk, and therefore should be

avoided during lactation

Should be taken with food.
May cause GI discomfort

40

BUDESONIDE 160 MCG AND
FORMOTEROL 4.5 MCG INHALATION

CATEGORY DESCRIPTION
PREGNANCY
LACTATION B3, C

SPECIAL COUNSELING POINT Administration of Symbicort should only
be considered if the expected benefit to
the mother is greater than any possible

risk to the child
Patient should rinse mouth with water
after each use to prevent oral fungal

infection. TeLl diabetic patients to
report difficulties with glycemic control

41

BUDESONIDE 200 MCG/DOSE
INHALATION

CATEGORY DESCRIPTION
PREGNANCY
LACTATION A, B

SPECIAL COUNSELING POINT Probably compatible.
The amounts of inhaled budesonide excreted

into breast milk are minute and infant
exposure is negligible. Most experts consider
oral and inhaled corticosteroids acceptable to

use during breastfeeding
Patient should rinse mouth with water after

each use to prevent oral fungal infection.

42

BUDESONIDE 64 MCG NASAL SPRAY

CATEGORY DESCRIPTION
PREGNANCY
LACTATION A, B

SPECIAL COUNSELING POINT Probably compatible.
The amounts of inhaled budesonide excreted
into breast milk are minute and infant exposure
is negligible. Most experts consider oral and
inhaled corticosteroids acceptable to use during

breastfeeding

Counsel patient to report vision changes or
signs of nasal or oropharyngeal candidiasis.
Nasal side effects may include nasal irritation

and septal perforation

43

CALCITRIOL 0.25 MCG CAPSULE

CATEGORY DESCRIPTION
PREGNANCY
LACTATION B3, C
SPECIAL COUNSELING POINT
Compatible

Side effects may include weakness,
headache, somnolence, nausea, anorexia,
and weight loss. Counsel patient to avoid
calcium-containing products that are not

prescribed or part of dietary plan

44

CALCIUM CARBONATE 500 MG TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C
SPECIAL COUNSELING POINT
Compatible

May be taken with or without food.
Take with meals for better absorption.
Avoid taking with large amount of fibre-

rich food

45

CALCIUM GLUCONATE 10% INJECTION

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C, Exempt
SPECIAL COUNSELING POINT
Infant risk cannot be ruled out

May cause tingling sensation, a sense of
oppression, or heat waves. Tell patients

to report signs/symptoms of
bradycardia or other arrythmias,

hypotension, or cardiac arrest

46

CALCIUM LACTATE 300 MG TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C
SPECIAL COUNSELING POINT
Safety has not been established

May be taken with or without food.
Take with meals for better absorption.

Avoid taking with large amount of
fibre-rich food

47

CAPTOPRIL 25 MG TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION D
SPECIAL COUNSELING POINT
Compatible

Take drug 1 h before meals. Report
symptoms of angioedema

Side effects may include rash,
arthralgia, flushing, cough, chest pain,

palpitations

48

CARBAMAZEPINE 200 MG TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION D
SPECIAL COUNSELING POINT
Compatible

Warn patients to report serious
dermatologic reactions. Take tablets
with foodAvoid activities requiring

coordination until drug effect are
realized as drug may cause dizziness and

drowsiness

49

CARBIMAZOLE 5 MG TABLET

CATEGORY DESCRIPTION
PREGNANCY D
LACTATION
SPECIAL COUNSELING POINT Compatible

May be taken with or without food.
Take consistently with or without

meal
Side effects may include nausea, mild
gastrointestinal disturbance, loss of

sense of taste, rash, pruritus,
urticaria, hair loss

50

CARVEDILOL 25MG TABLET

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
It is not known if it is present in breast
SPECIAL COUNSELING POINT milk

Bradycardia may be observed more
frequently in elderly patient.

51

CARVEDILOL 6.25MG TABLET

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
It is not known if it is present in breast
SPECIAL COUNSELING POINT milk

Bradycardia may be observed more
frequently in elderly patient.

52

CEFTRIAXONE 0.25G INJECTION

CATEGORY DESCRIPTION
PREGNANCY B
LACTATION
SPECIAL COUNSELING POINT Compatible
Advice patient to report severe
diarrhea and consult physician prior
taking anti-diarrhea medicine

53

CEPHALEXIN MONOHYDRATE
125MG/5ML SYRUP

CATEGORY DESCRIPTION
PREGNANCY B
LACTATION
SPECIAL COUNSELING POINT Acceptable. Infant risk is minimal
Advice patient to report severe
diarrhea and consult physician prior
taking anti-diarrhea medicine

54

CEPHALEXIN MONOHYDRATE 250MG
CAPSULE

CATEGORY DESCRIPTION
PREGNANCY B
LACTATION
SPECIAL COUNSELING POINT Acceptable. Infant risk is minimal
Advice patient to report severe
diarrhea and consult physician prior
taking anti-diarrhea medicine

55

CETIRIZINE HCL 10MG TABLET

CATEGORY DESCRIPTION
PREGNANCY
B
LACTATION (Should not be administered in first
SPECIAL COUNSELING POINT
trimester of pregnancy)
Present in breast milk. Acceptable in

the lowest effective dose
This drug may cause CNS depression
(somnolence). If affected, do not drive

or operate machinery

56

CETRIMIDE 1-2% LOTION

CATEGORY DESCRIPTION
PREGNANCY No data is available
LACTATION No data is available
SPECIAL COUNSELING POINT Avoid application to the eyes, body
cavities and badly inflamed skin

57

CHARCOAL ACTIVATED 250MG TABLET

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
SPECIAL COUNSELING POINT No data available
To be taken before meal or 2 hour
after meal. Avoid milk while taking this

medication

58

CHLORAMPHENICOL 0.5% EYE DROPS

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
Limited human data – Potential
SPECIAL COUNSELING POINT toxicity

Avoid prolonged use. Discard after 1
month opened

59

CHLORAMPHENICOL 1% EYE
OINTMENT

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
Limited human data – Potential
SPECIAL COUNSELING POINT toxicity

Avoid prolonged use

60

CHLORAMPHENICOL 5% W/V EAR
DROPS

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
Limited human data – Potential
SPECIAL COUNSELING POINT toxicity

Avoid prolonged use. Discard after 1
month opened

61

CHLORHEXIDINE GLUCONATE 1%
CREAM

CATEGORY DESCRIPTION
PREGNANCY B
LACTATION
SPECIAL COUNSELING POINT No human data. Probably campatible
-

62

CHLORPHENIRAMINE MALEATE
10MG/ML INJECTION

CATEGORY DESCRIPTION
PREGNANCY B
LACTATION
Present in breast milk. 2nd generation
SPECIAL COUNSELING POINT antihistamine preferred

This drug may cause CNS depression
(somnolence). If affected, do not drive

or operate machinery

63

CHLORPHENIRAMINE MALEATE
2MG/5ML SYRUP

CATEGORY DESCRIPTION
PREGNANCY B
LACTATION
SPECIAL COUNSELING POINT Present in breast milk.
This drug may cause CNS depression
(somnolence). If affected, do not drive
or operate machinery. Not for patient

below 2 years old

64

CHLORPHENIRAMINE MALEATE 4MG
TABLET

CATEGORY DESCRIPTION
PREGNANCY B
LACTATION
Present in breast milk. 2nd generation
SPECIAL COUNSELING POINT antihistamine preferred

This drug may cause CNS depression
(somnolence). If affected, do not drive

or operate machinery

65

CHLORPROMAZINE HCL 100MG TABLET

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
Present in breast milk. Limited human
SPECIAL COUNSELING POINT data

May cause extrapyramidal syndrome
(EPS) in patient

66

CHOLINE SALICYLATE 8.7%,
CETYLKONIUM CHLORIDE 0.01%

DENTAL GEL

CATEGORY DESCRIPTION
PREGNANCY No data available
LACTATION No data available
SPECIAL COUNSELING POINT Should not be used by infant under 4
months or patient with history of
salicylate sensitivity, active peptic
ulcer or hemophilia

67

CLOPIDOGREL 75MG TABLET

CATEGORY DESCRIPTION
PREGNANCY B
LACTATION
SPECIAL COUNSELING POINT No data available
Monitor signs of bleeding including

occult bleeding and bruises

68

CLOTRIMAZOLE 500MG VAGINAL
TABLET

CATEGORY DESCRIPTION
PREGNANCY B
LACTATION
SPECIAL COUNSELING POINT Excretion in breast milk is unknown
May reduce the efficacy and safety of
latex contraceptive such as condom

and diaphragm

69

CLOXACILLIN SODIUM 125MG/5ML
SUSPENSION

CATEGORY DESCRIPTION
PREGNANCY B
LACTATION
Distributed into milk but significant
SPECIAL COUNSELING POINT problem in human not documented

Advice patient to report severe
diarrhea and consult physician prior

taking anti-diarrhea medicine

70

CLOXACILLIN SODIUM 250MG CAPSULE

CATEGORY DESCRIPTION
PREGNANCY B
LACTATION
Distributed into milk but significant
SPECIAL COUNSELING POINT problem in human not documented

Advice patient to report severe
diarrhea and consult physician prior

taking anti-diarrhea medicine

71

CLOXACILLIN SODIUM 500MG CAPSULE

CATEGORY DESCRIPTION
PREGNANCY B
LACTATION
Distributed into milk but significant
SPECIAL COUNSELING POINT problem in human not documented

Advice patient to report severe
diarrhea and consult physician prior

taking anti-diarrhea medicine

72

COAL TAR WITH SALICYLIC ACID
(VARIOUS CONCENTRATIONS)

SOLUTION

CATEGORY DESCRIPTION
PREGNANCY No data available
LACTATION Not recommended
SPECIAL COUNSELING POINT Apply for 5 minutes then wash off. Do
not scratch the scalp as it will
worsened the psoriasis

73

COLCHICINE 0.5MG TABLET

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
Limited Human Data - Probably
SPECIAL COUNSELING POINT Compatible

Avoid grapefruit juice since can
increase serum colchicne level

74

COPPER 250 MM2 INTRAUTERINE
DEVICE

CATEGORY DESCRIPTION
PREGNANCY No data available
LACTATION No data available
SPECIAL COUNSELING POINT The IUD and its accessories should not
be reused and to be discard after used

75

CROTAMITON 10 % CREAM

CATEGORY DESCRIPTION
PREGNANCY C (Not advised during first trimester)
LACTATION Not known whether pass into breast

SPECIAL COUNSELING POINT milk
Should not allow direct contact with
conjunctiva, inflamed and wound skin

76

DEXAMETHASONE SODIUM
PHOSPHATE 4MG/ML INJECTION

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
SPECIAL COUNSELING POINT No data available
Avoid abrupt withdrawal or rapid dose

reduction

77

DEXTROSE 10% INJECTION

CATEGORY DESCRIPTION
PREGNANCY No data available
LACTATION No data available
SPECIAL COUNSELING POINT If any visible solid particle, growth or
turbidity appeared during storage, the
product should not be used.

78

DEXTROSE 5% INJECTION

CATEGORY DESCRIPTION
PREGNANCY No data available
LACTATION No data available
SPECIAL COUNSELING POINT If any visible solid particle, growth or
turbidity appeared during storage, the
product should not be used.

79

DEXTROSE 50% INJECTION

CATEGORY DESCRIPTION
PREGNANCY No data available
LACTATION No data available
SPECIAL COUNSELING POINT Discard all unused content. If any
visible solid particle, growth or
turbidity appeared during storage, the
product should not be used.

80

DEXTROSE POWDER

CATEGORY DESCRIPTION
PREGNANCY No data available
LACTATION No data available
SPECIAL COUNSELING POINT
-

81

DIAZEPAM 5MG/ML INJECTION

CATEGORY DESCRIPTION
PREGNANCY D
LACTATION
SPECIAL COUNSELING POINT Limited human data – Possible toxicity
This drug may cause CNS depression
(somnolence). If affected, do not drive

or operate machinery

82

DICLOFENAC 50MG TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C (Prior 30 weeks gestation)
SPECIAL COUNSELING POINT D (Starting 30 weeks gestation)

Present in breast milk. Not
recommended in breastfeed
NSAID can increase risk of serious
adverse cardiovascular thrombotic

event (eg. Mi and stroke)

83

DICLOFENAC SODIUM 75MG/3ML
INJECTION

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C (Prior 30 weeks gestation)
SPECIAL COUNSELING POINT D (Starting 30 weeks gestation)

Present in breast milk. Not
recommended in breastfeed
NSAID can increase risk of serious
adverse cardiovascular thrombotic

event (eg. Mi and stroke)

84

DIGOXIN 0.25 MG TABLET

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
Present in breast milk but not
SPECIAL COUNSELING POINT contraindicated

Arrhythmia may precipitate in digoxin
toxicity

85

DILTIAZEM HCL 30MG TABLET

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
Present in breast milk. Not
SPECIAL COUNSELING POINT recommended in breastfeed
It was reported that symptoms were
aggravated after sudden withdrawal of
medication. Dose should be reduced
gradually with symptoms monitoring

86